4.5 Article

Expression of promyelocytic leukemia protein and vascular endothelial growth factor in aqueous humor and vitreous fluid in patients with proliferative diabetic retinopathy

期刊

DIABETES RESEARCH AND CLINICAL PRACTICE
卷 98, 期 2, 页码 E9-E11

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2012.09.020

关键词

Angiogenesis; Diabetic retinopathy; Promyelocytic leukemia protein; Tumor suppressor; Vascular endothelial growth factor

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Takeda Science Foundation
  3. Funding Program for Next Generation World-Leading Researchers (NEXT Program)
  4. Grants-in-Aid for Scientific Research [23890254] Funding Source: KAKEN

向作者/读者索取更多资源

Aims: To examine the expression of promyelocytic leukemia protein (PML) in the eye of proliferative diabetic retinopathy (PDR) patients. Methods: PML mRNA levels were measured in proliferative membranes from 12 PDR patients and idiopathic epiretinal membranes from 5 control patients by quantitative RT-PCR. Protein levels of PML and vascular endothelial growth factor (VEGF) in aqueous humor and vitreous fluid samples from 34 PDR patients and 38 control patients were determined using ELISA. Results: The PML mRNA expression levels in membrane samples, and the PML protein concentrations in aqueous humor and vitreous fluid samples were significantly lower in PDR patients than control patients. We observed a statistically significant inverse correlation between the concentrations of PML and VEGF in the aqueous humor and vitreous fluid of PDR patients. Conclusion: PML may be a good candidate as a diagnostic marker and a therapeutic agent for PDR. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据